Guangfa Pharmaceutical Health Mixed Securities Investment Fund Prospectus
This is the Chinese-language prospectus (招募说明书) for the Guangfa Pharma Health Mixed Securities Investment Fund, a mixed securities investment fund managed by Guangfa Fund Management Co., Ltd. with Bank of China Co., Ltd. as fund custodian. The document states that the fund was approved for offering and registration by the China Securities Regulatory Commission on August 18, 2020 under document number 证监许可[2020]1855号.
The prospectus is organized into 24 parts, from definitions, fund manager and custodian, fund offering, subscription/redemption/conversion of fund shares, investment, valuation of fund assets, income and distribution, fees and taxes, information disclosure, side pocket mechanism, risk disclosure, through to the summary of the fund contract and custody agreement. It notes that the fund may invest in Hong Kong Stock Connect eligible stocks and lists risks including systemic risk, liquidity risk, management risk, fund-specific risk and early termination risk. This manual is written in Chinese.
| Fund Manager | 广发基金管理有限公司 |
|---|---|
| Fund Custodian | 中国银行股份有限公司 |
| Registration Approval Document | 证监许可[2020]1855号 |
| Registration Approval Date | 2020年8月18日 |
| Fund Type | 混合型证券投资基金 |
| Document Structure | 24 parts |
The fund is managed by Guangfa Fund Management Co., Ltd.
The custodian is Bank of China Co., Ltd.
It was approved on August 18, 2020 by the China Securities Regulatory Commission under 证监许可[2020]1855号.
It may invest in eligible Hong Kong Stock Connect stocks, but it may also choose not to invest in Hong Kong stocks.